Patent · US Active

Bio-hybrid material, production method therefor, and stent

US9428588B2 · kind B2 · utility

0Cited by
1References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 24, 2011
Grant dateAug 30, 2016
Priority date
Expiry dateNov 24, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61L2300/426
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

Provided is a bio-hybrid material that does not cause elution of nickel ions and has an excellent endothelialization ability, a production method therefor, and a stent. The bio-hybrid material (101) used includes an alloy part (11) free of Ni, an organic acid (12) having two or more active esters, and a cytokine (13). The alloy part (11) free of Ni forms an ester bond with the organic acid (12), and the organic acid (12) and the cytokine (13) are immobilized via an amide bond.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.